Outcomes of congenital heart disease: a review

Angela Green1

  • 1University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Pediatric Nursing
|October 30, 2004
PubMed

Insights

Congenital heart disease (CHD) affects one million Americans, causing physical, behavioral, and psychiatric issues. More research is needed on long-term outcomes for patients treated with modern medical advancements.

Area of Science:

  • Cardiology
  • Pediatric Medicine
  • Public Health

Background:

  • Congenital heart disease (CHD) impacts approximately one million Americans.
  • Improved survival rates highlight the multifaceted effects of CHD on patients' lives.
  • Existing research indicates challenges in physical growth, motor function, and exercise tolerance.

Purpose of the Study:

  • To review the current understanding of the impact of congenital heart disease (CHD) on affected individuals.
  • To identify areas where more research is needed regarding CHD outcomes.
  • To examine the long-term effects of CHD, particularly in patients managed with contemporary medical technologies.

Main Methods:

  • Literature review of studies on congenital heart disease (CHD) outcomes.
  • Analysis of reported physical, behavioral, and psychiatric effects in children and adults with CHD.
  • Synthesis of data concerning quality of life (QOL) in CHD populations.

Main Results:

  • Patients with CHD frequently experience issues with physical growth and gross motor development.
  • Adults with CHD, even those with minor defects, often exhibit reduced exercise tolerance.
  • Adolescents and young adults with CHD show increased prevalence of behavioral and psychiatric conditions, including depression and anxiety disorders.

Conclusions:

  • Congenital heart disease (CHD) presents a complex spectrum of lifelong challenges.
  • Current data on quality of life (QOL) in CHD patients are conflicting and require further investigation.
  • There is a critical need for comprehensive outcome research on individuals diagnosed, managed, and repaired using modern CHD treatment strategies.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...